KKKoichi Kawamoto

Koichi Kawamoto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Koichi Kawamoto has a total of 102 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hereditary Pancreatitis Model by Blastocyst Complementation in Mouse

    by Ayumu Asai, Masamitsu Konno, Jun Koseki, Koichi Kawamoto, Takahiro Arai, Taroh Satoh, Hidetoshi Eguchi, Masaki Mori, Yuichiro Doki, Hideshi Ishii

    Summary Statement: The present study is the first report for reproducing human disease by utilizing blastocyst complementation method and would lead to the development of novel therapy for human disease. The application of pluripotent stem cell is expected to contribute to the elucidation of the unknown mechanism of human diseases. However, in vitro induction of cells in several organs, such as the pancreas and liver, remains difficult; therefore, reproduction of those diseases in a model has not been feasible. To reproduce human hereditary pancreatitis (HP), which is most frequently caused by the mutations in the PRSS1 gene, we performed the blastocyst complementation (BC) method. In the BC method, mouse embryonic stem (ES) cells harboring CRISPR/CAS9-mediated mutations in the Prss1 were injected into the blastocysts of deficient Pdx1 gene mice, which is a critical transcription factor in the pancreas. The results showed that the blastocysts injected into the Prss1 -mutant ES cells induced trypsin activation. This implied that the mouse phenotype mimics that of human HP and that the BC method was useful for the reproduction and study of pancreatic disorders. The present study opens the possibility of investigating uncharacterized human diseases by utilizing the BC method.

  • The Risk Factors of Post-Transplant Bacteremia in Living Donor Liver Transplantation

    by Kunihito Gotoh, Hidetoshi Eguchi, Yoshifumi Iwagumi, Daisaku Yamada, Tadafumi Asaoka, Takehiro Noda, Koichi Kawamoto, Shogo Kobayashi, Koji Umeshita, Yuichiro Doki, et al.


  • Plasma ghrelin suppression as an early predictor for postoperative complications after pancreatoduodenectomy

    by Kazuki Sasaki, Tadafumi Asaoka, Hidetoshi Eguchi, Yasunari Fukuda, Yoshifumi Iwagami, Daisaku Yamada, Yasuhiro Miyazaki, Takehiro Noda, Tsuyoshi Takahashi, Kunihito Gotoh, et al.


  • The basal nutritional state of PDAC patients is the dominant factor for completing adjuvant chemotherapy

    by Daisaku Yamada, Hidetoshi Eguchi, Tadafumi Asaoka, Hideo Tomihara, Takehiro Noda, Hiroshi Wada, Koichi Kawamoto, Kunihito Gotoh, Yutaka Takeda, Masahiro Tanemura, et al.


    • 1 November 2015
      • Vol. 42  (12) , 1638-40

    [Complete Surgical Resection of a Huge Hepatocellular Carcinoma Invading the Diaphragm and Lung after Transcatheter Arterial Chemoembolization (TACE) and Sorafenib--A Case Report].

    by Yosuke Mukai, Hiroshi Wada, Hidetoshi Eguchi, Akira Tomokuni, Yoshito Tomimaru, Tadafumi Asaoka, Koichi Kawamoto, Shigeru Marubashi, Koji Umeshita, Yuichiro Doki, et al.

    We report a case of locally advanced huge hepatocellular carcinoma (HCC) invading the diaphragm and the right lung, which was controlled by sorafenib, thereby allowing curative resection. A 72-year-old man was diagnosed with advanced HCC invading the diaphragm and the right lung. At the time of diagnosis, his tumor was considered unresectable and he underwent transarterial embolization (TAE)/transcatheter arterial chemoembolization (TACE) 3 times. Assessment with enhanced CT after TAE/TACE showed that a viable lesion remained. Subsequently, he was treated with sorafenib for 15 months. Reassessment showed that the main tumor remained stable in size, and he was admitted to our hospital for surgery. Preoperative evaluation by enhanced CT and MRI detected an intrahepatic metastasis in segment 4 of the liver. After TACE was performed for this nodule, extended right hemihepatectomy with right diaphragmatic and right lung partial resection was performed. He had no postoperative complications and was discharged 27 days after surgery. He remains alive without recurrence 10 months after surgery.


    • 1 November 2015
      • Vol. 42  (12) , 1854-6

    [A Case of Surgical Resection of a Liver Metastasis from Colorectal Cancer with a Macroscopic Portal Vein Tumor Thrombus].

    by Kazuki Sasaki, Yoshito Tomimaru, Hiroshi Wada, Hisataka Ogawa, Daisaku Yamada, Akira Tomokuni, Tadafumi Asaoka, Takehiro Noda, Kunihito Gotoh, Koichi Kawamoto, et al.

    The patient was a 65-year-old man. In July 2014, he was diagnosed with rectal cancer in a different hospital and underwent high anterior resection(type 2, T3N0M0, StageⅡ [TMN classification, 7th edition]). During the operation, a small nodule was detected in segment 4 of the liver. Contrast-enhanced abdominal CT revealed a tumor measuring 5 cm in diameter located in segment 4/8 of the liver with a tumor thrombus in the main trunk of the portal vein. In August 2014, the patient was referred to our hospital for further examination and treatment. MR imaging showed a lobulated tumor located in segment 4/8 of the liver. Gadoxeticac id-enhanced hepatobiliary phase MR imaging showed that the tumor was less enhanced than was the adjacent liver parenchyma. 18F-FDG-PET/CT demonstrated abnormal accumulation of 18F-FDG in the main tumor(SUVmax=18.3). There was no obvious abnormal accumulation in the other organs. In September 2014, he underwent extended left hepatectomy and portal vein tumor thrombectomy. The resected specimen showed a well-differentiated adenocarcinoma. Immunohistochemical staining results were CK7/CK20 (-/+) and CDX2 (+), which suggested that the tumor was derived from the gastrointestinal tract rather than the liver. The pathological diagnosis was a liver metastasis from rectal cancer. In the 6 months after the operation, intrahepatic recurrence was detected, and the patient was treated with systemicchemotherapy.


    • 1 November 2015
      • Vol. 42  (12) , 2181-3

    [A Successful Curative Resection Including Replacement with a Ringed Gore-Tex Tube Graft for Local Recurrence after Right Adrenalectomy and Liver Metastasis of Colon Cancer with Inferior Vena Cava Invasion].

    by Kenji Sakai, Hiroshi Wada, Hidetoshi Eguchi, Hisataka Ogawa, Daisaku Yamada, Yoshito Tomimaru, Akira Tomokuni, Tadafumi Asaoka, Takehiro Noda, Kunihito Gotoh, et al.

    A 65-year-old woman underwent sigmoidectomy for colon cancer in January 2002. She had multiple liver metastases and received systemic chemotherapy (UFT-E plus CPT-11) for 6 months. She underwent partial hepatectomy of S7 and S3 and cholecystectomy in July 2003. After 4 years without recurrence, right adrenal and para-aortic lymph nodes metastases were detected and she underwent right adrenalectomy and para-aortic lymphadenectomy in July 2007. In July 2008, local recurrence (1 cm in size) was identified in the cavity of the right adrenal gland. She received chemotherapy (mFOLFOX6 plus bevacizumab) for 5 years. In May 2013, PET-CT showed abnormal accumulation of FDG in S7 of the liver (SUVmax 6.7). The enhanced EOB-MRI showed a mass lesion in S7 (3 cm in size) and 2 nodules (1 cm in size) in S3 and S4. We scheduled for liver surgery with reconstruction of the inferior vena cava (IVC) after systemic chemotherapy (FOLFIRI plus cetuximab). The patient underwent partial hepatectomy of the tumor in S7 combined with resection of the diaphragm and IVC. Reconstruction of the IVC was performed using a ringed Gore-Tex tube graft in February 2014. The patient is still alive without recurrence 18 months after surgery.


    • 1 November 2015
      • Vol. 42  (12) , 2346-8

    [Three Resected Cases of Metachronous Pancreatic Cancer Successfully Treated with Repeated Pancreatectomy].

    by Kozo Noguchi, Yoshito Tomimaru, Hidetoshi Eguchi, Hisataka Ogawa, Daisaku Yamada, Akira Tomokuni, Takehiro Noda, Tadafumi Asaoka, Hiroshi Wada, Koichi Kawamoto, et al.

    Repeated pancreatectomy for metachronous pancreatic cancer has rarely been reported. We report 3 cases with metachronous pancreatic ductal carcinoma that developed after pancreatectomy for the first pancreatic cancer. They were successfully resected by removal of the remnant pancreas. In all 3 cases, the cancers in the remnant pancreas were treated with repeated pancreatectomy. The histological margin of the first pancreatic resection was cancer-free in all the cases. Furthermore, the second cancer tissue contained carcinoma lesions in situ adjacent to invasive ductal carcinoma. Based on these findings, the 3 patients were diagnosed with metachronous pancreatic cancers.

    • 1 September 2015
      • Vol. 42  (9) , 1036-9

    [Therapeutic Implication Targeting for Cancer Stem Cells].

    by Kozo Noguchi, Masamitsu Konno, Naohiro Nishida, Koichi Kawamoto, Jun Koseki, Hidetoshi Eguchi, Yuichiro Doki, Masaki Mori, Taro Satoh, Hideshi Ishii

    Cancer has been viewed as a heterogeneous population of cells.While the large majority of cells that constituting tumors are differentiated, and eventually stop dividing, only a minority population of cells, termed cancer stem cells, is capable of unlimited self-renewal and multi-differentiation, just like somatic stem cells in normal tissues.Cancer stem cells have been identified in a variety of cancers of the blood, brain, stomach, colon, and pancreas.In this review we present current evidence supporting the cancer stem cell model of tumor progression, and discuss the experimental and therapeutic implications.


    • 1 November 2014
      • Vol. 41  (12) , 1512-4

    [A case of initially unresectable pancreatic cancer with arterial invasion successfully resected after chemotherapy].

    by Tomofumi Ohashi, Yoshito Tomimaru, Hidetoshi Eguchi, Naoki Hama, Akira Tomokuni, Tadafumi Asaoka, Hiroshi Wada, Koichi Kawamoto, Shogo Kobayashi, Shigeru Marubashi, et al.

    A 63-year-old man was diagnosed with pancreatic head cancer, and an operation was planned at his previous hospital. However, resection was not possible because of invasion of the superior mesenteric artery, and gemcitabine-based chemotherapy was administered for the tumor for 2 years. Imaging examinations after chemotherapy were unable to detect the tumor at the pancreatic head or the arterial invasion. The patient was subsequently referred to our hospital for surgery. Upon laparotomy, the tumor was judged to be resectable, and a pancreaticoduodenectomy was performed. Pathological examination indicated the presence of cancer cells in the resected specimens. The patient underwent adjuvant chemotherapy and is currently alive without recurrence. This case highlights the importance of ongoing follow-up in patients with locally advanced pancreatic cancer so that tumor resectability can be evaluated during chemotherapy.